Overview
Reference Number: JO-2101-460568
Global Medical Director – Oncology/Rare Diseases
Rate: Negotiable
Job Type: Permanent
Location: Central London / West End
Global Medical Director Oncology and Rare Diseases
Salary: Executive Level
Benefits: Car allowance, bonus, pension, healthcare
JO-2101-460568
A global pharmaceutical company are seeking a Senior Medical Affairs Physician to join their global team, leading on some of their extremely exciting Rare Oncology and Rare Disease products. This business has seen a lot of growth and expansion in the last 5 years and they are looking to find a dynamic, global Physician to help continue this trend and shape strategy and the Emerging Markets further and area of rare oncology further.
Requirements:
Medically qualified and GMC registered
Global Medical Affairs experience
Oncology/Rare Disease experience
Responsibilities will include:
Leading the global medical affairs activities, with a focus on Emerging Markets
Support the Region in any scientific projects
Support the Region in any negotiation with health authorities
Managing and developing both existing and new medical activities to deliver commercial success
Develop and implement global plans to deliver medical strategy
Develop a strong KOL/Advisor Network across the Region
Please apply in order to receive the full job description.
Remuneration:
The successful candidate would receive a competitive annual salary package plus an excellent benefits package including the likes of a car allowance, bonus, private healthcare, pension scheme and much more.
Contact/How to Learn More:
To find out more information or apply, contact Caroline Rogers on 0118 952 2799 or email caroline.rogers@cpl.com
The Medical Division at Cpl Life Sciences (previously Only Medics/Clinical Professionals) is a specialist division that focuses exclusively on recruitment of Medical Affairs, Clinical Development & Pharmacovigilance for pharmaceutical companies, biotechnology companies, Clinical Research Organisations (CROs) and Regulatory Authorities.